Related by context. Frequent words. (Click for all words.) 78 Dasatinib 76 Lenalidomide 74 Erlotinib 74 Monotherapy 73 Irinotecan 73 Natalizumab 73 Epratuzumab 73 Phase III Trial 73 Bevacizumab 73 Capecitabine 72 Etanercept 72 Enoxaparin 72 Aliskiren 72 tigecycline 72 Patients Treated 72 Pioglitazone 72 Clinical Trial Results 72 Adalimumab 72 Combination Therapy 72 Combination therapy 72 Alemtuzumab 72 Allergic Rhinitis 71 Metastatic Colorectal Cancer 71 Bortezomib 71 Pivotal Phase III 71 Imatinib 71 Well Tolerated 71 Oxaliplatin 71 Drug Candidate 71 Overactive Bladder 71 Cyclosporine 71 Gemzar ® 70 Elderly Patients 70 Phase III Clinical Trial 70 Ischemic 70 daunorubicin 70 nucleoside analogue 70 Chronic Lymphocytic Leukemia 70 Eltrombopag 70 Fidaxomicin 70 Advanced Prostate Cancer 69 Voreloxin 69 Telmisartan 69 Pivotal Phase 69 Laquinimod 69 Benign Prostatic Hyperplasia 69 Pulmonary Arterial Hypertension 69 Chronic Hepatitis C 69 Atopic Dermatitis 69 Gemcitabine 68 Amrubicin 68 liposomal formulation 68 angiotensin converting enzyme inhibitors 68 Tolerability 68 Trastuzumab 68 mycophenolate mofetil 68 Boceprevir 68 Immunogenicity 68 C Reactive Protein 68 Traficet EN 68 Anastrozole 68 Low Dose 68 Docetaxel 68 Vandetanib 68 Chronic Heart Failure 68 Infliximab 68 Sorafenib 68 luteinizing hormone releasing 68 Cisplatin 68 DOXIL 68 Ramipril 68 gastrointestinal stromal tumors GIST 68 Everolimus 68 Study Demonstrates 68 Celecoxib 67 azacitidine 67 Lamivudine 67 Monoclonal Antibody 67 Cethromycin 67 Cardiovascular Events 67 Vfend 67 Heart Failure Patients 67 Lacosamide 67 mTOR inhibitor 67 Diabetic Patients 67 Rituximab 67 Pivotal Trial 67 Drug Resistant 67 Pirfenidone 67 Rheumatoid Arthritis RA 67 Prophylaxis 67 NOXAFIL 67 Completes Enrollment 67 J Am Coll 66 Ofatumumab 66 Inhibits 66 imatinib mesylate 66 Antihypertensive 66 Subcutaneous 66 temsirolimus 66 Rivaroxaban